Article summary
This qualitative study interviewed 12 healthy adults after movement tasks under psilocybin doses of 5β20 mg. Participants described mixed changes in movement, coordination and reaction time that interacted with attention, motivation, sensory changes and dose; these accounts do not establish an objective motor-performance benefit.
Continue to the original publication for the complete article.